Drug Approval | March 31, 2026
Teva hits major biosimilar milestones with FDA nod and regulatory filings
The US FDA has approved PONLIMSI (denosumab-adet) as a biosimilar to Prolia
The US FDA has approved PONLIMSI (denosumab-adet) as a biosimilar to Prolia
Over the past few months, Apollo Hospitals has entered into MoUs with multiple national and international air ambulance service providers
The campaign highlights a straightforward, achievable approach to health, proving that supporting your wellness doesn’t have to be complicated
The programme aims to provide critical healthcare services to approximately 4 lakh people in remote and resource-scarce communities
As Tracky launches integrated health solution
The milestone moves the company closer to its previously announced $120 million US expansion, with groundbreaking slated for late 2026
The Trust’s shift from single-use compostable cups to a reusable system was driven by the need to reduce environmental impact and control long-term costs
The collaboration will see HNL Lab Medicine deploy Ibex’s cutting-edge AI solution, Ibex Prostate, for biopsies and transurethral resection of the prostate (TURP), boosting both diagnostic accuracy and workflow efficiency
The Cambridge hub is designed to expand Zealand Pharma’s global research capabilities
The timing of the partnership is crucial, as Kerala’s fertility rate has dropped to approximately 1.35–1.7 children per woman, below the replacement level of 2.1
Subscribe To Our Newsletter & Stay Updated
